Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection
Mayor, A.M.; Gomez, M.A.; Fernandez, D.M.; Rios-Olivares, E.; Thomas, J.C.; Hunter, R.F.
American Journal of Tropical Medicine and Hygiene 74(2): 239-245
2006
ISSN/ISBN: 0002-9637 PMID: 16474077 Document Number: 597983
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection is ail important and frequent scenario, predominantly in injecting drug Users (IDUs). The present study evaluated morbidity and mortality variation in HIV-infected patients with and without HCV co-infection. Co-infection prevalence was determined in 356 HIV-infected persons. Their clinical manifestations, laboratory findings, risk factors, HIV therapies, and mortality rates Were evaluated. The prevalence of HCV was 54% in the overall group and 81% in IDUs, with a predominance of HCV genotype 1. Mortality rates were similar in patients with and without co-infection; however, co-infected patients had significantly higher liver damage as a cause of mortality when compared with those who were not co-infected. The high prevalence of HCV and ail emerging mortality from liver diseases showed the significance of this co-infection in the HIV epidemic. Primary and secondary prevention are necessary to reduce the expanding impact of HCV infection in HIV patients.
Document emailed within 1 workday
Related Documents
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Chasela, C.S.; Wall, P.; Drobeniuc, J.; King, C.C.; Teshale, E.; Hosseinipour, M.C.; Ellington, S.R.; Codd, M.; Jamieson, D.J.; Knight, R.J.; Fitzpatrick, P.; Kourtis, A.P.; Hoffman, I.F.; Kayira, D.; Mumba, N.; Kamwendo, D.D.; Martinson, F.; Powderly, W.; van der Horst, C.; Kamili, S.; Adair, L.; Ahmed, Y.; Ait-Khaled, M.; Albrecht, S.; Bangdiwala, S.; Bayer, R.; Bentley, M.; Bramson, B.; Bobrow, E.; Boyle, N.; Butera, S.; Chasela, C.; Chavula, C.; Chimerang'ambe, J.; Chigwenembe, M.; Chikasema, M.; Chikhungu, N.; Chilongozi, D.; Chiudzu, G.; Chome, L.; Cole, A.; Corbett, A.; Corneli, A.; Dow, A.; Duerr, A.; Eliya, H.; Ellington, S.; Eron, J.; Farr, S.; Ferguson, Y.O.; Fiscus, S.; Flax, V.; Fokar, A.; Galvin, S.; Guay, L.; Heilig, C.; Hoff 2012: Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 318-320
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Chilongozi, D.; Wang, L.; Brown, L.; Taha, T.; Valentine, M.; Emel, L.; Sinkala, M.; Kafulafula, G.; Noor, R.A.; Read, J.S.; Brown, E.R.; Goldenberg, R.L.; Hoffman, I.; Taha, T.E.; Goldenberg, R.; Kumwenda, N.; Kafulafula, G.; Martinson, F.; Msamanga, G.; Sinkala, M.; Stringer, J.; Hoffman, I.; Fawzi, W.; Broadhead, R.; Liomba, G.; Kumwenda, J.; Mebrahtu, T.; Katunda, P.; Dahab, M.; Kazembe, P.; Chilongozi, D.; Chasela, C.; Joaki, G.; Dzinyemba, W.; Kamanga, S.; Lyamuya, E.; Kilewo, C.; Manji, K.; Kaaya, S.; Aboud, S.; Sheriff, M.; Saathoff, E.; Satow, P.; Ballonzi, I.; Antelman, G.; Basheka, E.; Mudenda, V.; Kaseba, C.; Njobvu, M.; Kabaso, M.; Kapina, M.; Yeta, A.; Kaminsa, S.; Malama, C.; Potter, D.; Ukwimi, M.; Taylor, A.; Chipaila, P.;, 2008: Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania Pediatric Infectious Disease Journal 27(9): 808-814
Chilongozi, D.; Wang, L.; Brown, L.; Taha, T.; Valentine, M.; Emel, L.; Sinkala, M.; Kafulafula, G.; Noor, R.A.; Read, J.S.; Brown, E.R.; Goldenberg, R.L.; Hoffman, I.; Taha, T.E.; Goldenberg, R.; Kumwenda, N.; Kafulafula, G.; Martinson, F.; Msamanga, G.; Sinkala, M.; Stringer, J.; Hoffman, I.; Fawzi, W.; Broadhead, R.; Liomba, G.; Kumwenda, J.; Mebrahtu, T.; Katunda, P.; Dahab, M.; Kazembe, P.; Chilongozi, D.; Chasela, C.; Joaki, G.; Dzinyemba, W.; Kamanga, S.; Lyamuya, E.; Kilewo, C.; Manji, K.; Kaaya, S.; Aboud, S.; Sheriff, M.; Saathoff, E.; Satow, P.; Ballonzi, I.; Antelman, G.; Basheka, E.; Mudenda, V.; Kaseba, C.; Njobvu, M.; Kabaso, M.; Kapina, M.; Yeta, A.; Kaminsa, S.; Malama, C.; Potter, D.; Ukwimi, M.; Taylor, A.; Chipaila, P.;, 2008: Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania Pediatric Infectious Disease Journal 27(9): 808-814
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Lecot, C.; Jeantils, V.; Ovaguimian, L.; Krivitzky, A.; Bréchot, C.; Dény, P. 1993: Polymerase chain reaction-based detection of hepatitis D virus RNA in patients infected with human immunodeficiency virus Progress in Clinical and Biological Research 382: 329-335
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Begovac, J.; Romih, V. 2009: Treatment of chronic hepatitis C in human immunodeficiency virus infected patients Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(5): 423-429
Ramos Paesa, C.; Arazo Garcés, P.; Pascual Catalán, A.; Hermida Lazcano, I.; Aguirre Errasti, J.M. 1998: Characteristics of chronic hepatitis C in patients infected by human immunodeficiency virus Revista Clinica Espanola 198(4): 207-211
Rebbani, K.; Ouladlahsen, A.; Bensghir, A.; Akil, A.; Lamdini, H.; Issouf, H.; Brahim, I.; Kitab, B.; Fakhir, F.Z.; Wakrim, L.; Marhoum El Filali, K.; Himmich, H.; Ezzikouri, S.; Benjelloun, S. 2013: Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 19(10): E454-E457
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Swaminathan, S.; Padmapriyadarsini, C.; Ponnuraja, C.; Sumathi, C.H.; Rajasekaran, S.; Amerandran, V.A.; Reddy, M.; Deivanayagam, C.N. 2007: Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: clinical profile and response to shortcourse chemotherapy Journal of Postgraduate Medicine 53(4): 228-231
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Eulalia Valencia, M.; Enríquez, A.; Soriano, V.; Moreno, V.; Laguna, F.; González Lahoz, J. 1997: Nosocomial infection with methicillin resistant Staphylococcus aureus in 14 human immunodeficiency virus infected patients Medicina Clinica 109(7): 261-263